Mediterranean diet and metabolic outcomes in nafld/masld: A systematic review and meta-analysis of randomized controlled trials
Archivos
Fecha
2026-10
Nota de Acceso
Fecha de embargo
Profe guía
Perfil ORCID
Título de la revista
ISSN de la revista
Título del volumen
Editor
Elsevier Ltd.
ISBN
ISSN
ISSNe
2405-4577
Resumen
Non-alcoholic fatty liver disease (NAFLD), recently redefined as metabolic dysfunction-associated steatotic liver disease (MASLD), is a leading cause of chronic liver disease worldwide. The Mediterranean diet (MD) is widely recommended for its metabolic benefits, but its specific impact on NAFLD/MASLD outcomes remains variable across trials. This systematic review and meta-analysis evaluated the effect of the Mediterranean diet on liver steatosis, liver enzymes, and metabolic markers in patients with NAFLD/MASLD. Larger, high-quality randomized trials with standardized dietary definitions and longer follow-up are required to clarify its therapeutic role in NAFLD/MASLD.
Descripción
Lugar de Publicación
Países Bajos
Sponsorship
Citación
Clinical Nutrition ESPEN, Vol. 75 (2026) pp. 1-15
Palabras clave
Mediterranean diet, NAFLD, MASLD, Non-alcoholic fatty liver disease, Metabolic dysfunction-associated steatotic liver disease, Systematic review, Meta-analysis, Randomized controlled trials
Licencia
Atribución-NoComercial-CompartirIgual 3.0 Chile (CC BY-NC-SA 3.0 CL)